NCT06947850View on ClinicalTrials.gov

DOMPE -MT Neurotrophic Keratitis

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 21, 2023

Primary Completion Date

September 25, 2025

Study Completion Date

September 25, 2025

Conditions
Dry EyeNeurotrophic Keratitis
Interventions
DRUG

Cenegermin Ophthalmic Solution [Oxervate]

Oxervate (cenegermin-bkbj) is commonly used to treat neurotrophic keratitis

Trial Locations (1)

37215

Toyos Clinic, Nashville

All Listed Sponsors
lead

Toyos Clinic

OTHER